Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
SHORT INTEREST
669.36K 09/13/19
P/E Current
-0.36
P/E Ratio (with extraordinary items)
-0.62
Average Recommendation: BUY
Average Target Price: 2.00
SHORT INTEREST
669.36K 09/13/19
P/E Current
-0.36
P/E Ratio (with extraordinary items)
-0.62
Average Recommendation: BUY
Average Target Price: 2.00
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media
1) Download our Mobile App >>
Android: dexwirenews.com/APP
Apple: dexwirenews.com/iOS
2) Join our Telegram >> t.me/DEXWireNews
3) Follow @DEXWireNews on Social Media